Sudarshan Pharma Industries Board of Directors
Get the latest insights into the leadership at Sudarshan Pharma Industries. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Hemal Vasantrai Mehta | Chairman & Managing Director |
| Mr. Sachin V Mehta | Founder & Joint Managing Director |
| Mrs. Jaya Ankur Singhania | Independent Director |
| Dr. Umesh Luthra | Independent Director |
| Dr. Anil Ghogare | Independent Director |
| Mr. Rushabh Patil | Independent Director |
Sudarshan Pharma Industries Share price
SUDARSHAN
32.1
0.62 (1.97%)Last updated on 4 Sep, 2025 | 15:15 IST
BUYSELL
Today's High
32.10
Today's Low
30.87
52 Week Low
18.60
52 Week High
53.50
The current prices are delayed, login to your account for live prices
LoginSudarshan Pharma Industries FAQs
The board at Sudarshan Pharma Industries consists of experienced professionals, including Mr. Hemal Vasantrai Mehta , Mr. Sachin V Mehta , and others, overseeing the company’s strategic and corporate governance.
Directors at Sudarshan Pharma Industries are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Hemal Vasantrai Mehta is the current chairman at Sudarshan Pharma Industries.
Executive directors at Sudarshan Pharma Industries are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sudarshan Pharma Industries adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sudarshan Pharma Industries, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.